Subsequently, two RCTs111, 118were performed where bone marrow-derived MSCs was combined with G-CSF, one in patients with decompensated alcoholic liver disease and the other in those with compensated cirrhosis (randomized against treatment with SMT or G-CSF alone, respectively). This evidence concerns the gene CSF3 and alcoholic liver diseases.